Le Lézard
Classified in: Health, Business
Subject: PER

Bruno Ultra BARCELOS is appointed Managing Director of Ethypharm UK

SAINT-CLOUD, France, Jan. 31, 2023 /PRNewswire/ -- The Ethypharm Group appoints Bruno Ultra BARCELOS as Managing Director of its UK subsidiary.

Bruno Ultra BARCELOS holds an Executive MBA from Kellogg-WHU He has 30 years of experience in Europe with large international pharmaceutical groups, specialising in both specialities, biosimilars and generic medicines (Schering-Plough, Teva Pharmaceuticals, Novartis Group). Bruno has held increasingly responsible commercial positions in both sales and marketing, up to General Management positions in Europe. He joins Ethypharm from Sandoz, where he was Country Head for Belgium and Luxembourg.

Bruno Ultra BARCELOS joins the Ethypharm Group as Managing Director of the Ethypharm UK subsidiary, Ethypharm's first commercial affiliate, representing 30% of its turnover.

"I am proud to join Ethypharm and very excited about this new challenge. As Managing Director of Ethypharm UK I will continue to foster a growth mindset and focus the teams on the opportunities ahead.  I look forward to leading the talented people in place to continue to develop and grow our business, with a focus on the service to our customers and on the safety and quality of our medicines," says Bruno Ultra BARCELOS. 

About Ethypharm

Ethypharm is a European pharmaceutical company focused on two areas: the Central Nervous System and Hospital injectables. Ethypharm markets its drugs directly in Europe and China, and with partners in North America and the Middle East. The Group employs 1,500+ people, mainly in Europe and China.

Ethypharm works closely with authorities and healthcare professionals to ensure the appropriate use of and access to its medicines, by as many people as possible.

For more information about Ethypharm, visit http://www.ethypharm.com and follow us on LinkedIn.

Photo - https://mma.prnewswire.com/media/1992088/Bruno_Barcelos_Ethyparm_UK.jpg
Logo - https://mma.prnewswire.com/media/1992089/Ethypharm_Logo.jpg

Press Contact

Ethypharm: Avril Ponnelle,  [email protected] 

These press releases may also interest you

at 01:25
BTCEX, one of the major cryptocurrency exchanges, has announced a partnering program with W Economy TV, a leading cryptocurrency consulting brand. The partnership aims to share policies and information and create meaningful synergy for customized...

at 00:01
ATTOM, a leading curator of land, property, and real estate data, today released its year-end 2022 U.S. Home Flipping Report, which shows that 407,417...

at 00:00
Gogoro Inc. and Cycle & Carriage Singapore (C&C) announced a partnership with leading food delivery platform foodpanda in a battery swapping pilot that will support smart electric two-wheel vehicles for last mile deliveries in Singapore. The...

22 mar 2023
TDG Gold Corp. ("TDG" or the "Company") , is pleased to announce that it has entered into an agreement with Raymond James Ltd. on behalf of a syndicate of agents (collectively, the "Agents"), pursuant to which the Agents agree to offer for sale on...

22 mar 2023
TSX VENTURE COMPANIES ALVOPETRO ENERGY LTD.  ("ALV")BULLETIN TYPE:  Declaration of DividendBULLETIN DATE:  March 22, 2023TSX Venture Tier 2 Company The Issuer has declared the following dividend: Dividend per common share:  US$0.14Payable Date: ...

22 mar 2023
DURACORE, a manufacturer of high-performance active living products, has entered into an exclusive partnership with Five at Heart, a leading provider of bike room, change room, and modern office solutions based in Brisbane, Australia. The partnership...

News published on 31 january 2023 at 04:00 and distributed by: